Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 7/20 | 0.47 |
| ▸ | HAO1 | Q9UJM8 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.37 |
| ▸ | MTOR | P42345 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.35 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL402092 | 0.86 | GRM5 (0.50) | GRM5HAO1 | |
| SCHEMBL15870932 | 0.84 | GRM5 (0.59) | GRM5HAO1 | |
| SCHEMBL31286309 | 0.84 | GRM5 (0.59) | GRM5HAO1 | |
| SCHEMBL1105471 | 0.82 | GRM5 (0.53) | GRM5HAO1 | |
| SCHEMBL28277896 | 0.82 | HAO1 (0.44) | GRM5HAO1 | |
| SCHEMBL7873467 | 0.82 | GRM5 (0.44) | GRM5HAO1 | |
| SCHEMBL7421591 | 0.80 | GRM5 (0.46) | GRM5HAO1FFAR1 | |
| SCHEMBL1820120 | 0.76 | HDAC8 (0.58) | GRM5HDAC8PIK3CAMTORFFAR1 | |
| SCHEMBL31673060 | 0.75 | GRM5 (0.55) | GRM5FFAR1 | |
| SCHEMBL1649302 | 0.74 | HDAC8 (0.55) | GRM5HDAC8PIK3CAMTORCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435365-B2 | Luminescent lanthanide(III) chelates | UNIOGEN OY (FI) | 2025-10-07 | — | — | US | claimed |
| EP-4073204-B1 | LUMINESCENT LANTHANIDE(III) CHELATES | UNIOGEN OY (FI) | 2023-08-09 | — | — | EP | claimed |
| US-20230025102-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | UNIOGEN OY (FI) | 2023-01-26 | — | — | US | claimed |
| EP-4073204-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | Abacus Diagnostica OY (FI) | 2022-10-19 | — | — | EP | claimed |
| CN-114929835-A | Luminescent lanthanide (III) chelates | 阿巴库司戴格奴司蒂可公司 | 2022-08-19 | — | — | CN | claimed |
| WO-2021116528-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | ABACUS DIAGNOSTICA OY (FI) | 2021-06-17 | — | — | WO | claimed |
| US-12435365-B2 | Luminescent lanthanide(III) chelates | UNIOGEN OY (FI) | 2025-10-07 | — | — | US | disclosed |
| EP-4073204-B1 | LUMINESCENT LANTHANIDE(III) CHELATES | UNIOGEN OY (FI) | 2023-08-09 | — | — | EP | disclosed |
| EP-4073204-B1 | LUMINESCENT LANTHANIDE(III) CHELATES | UNIOGEN OY (FI) | 2023-08-09 | — | — | EP | disclosed |
| US-20230025102-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | UNIOGEN OY (FI) | 2023-01-26 | — | — | US | disclosed |
| US-20230025102-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | UNIOGEN OY (FI) | 2023-01-26 | — | — | US | disclosed |
| EP-4073204-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | Abacus Diagnostica OY (FI) | 2022-10-19 | — | — | EP | disclosed |
| CN-114929835-A | Luminescent lanthanide (III) chelates | 阿巴库司戴格奴司蒂可公司 | 2022-08-19 | — | — | CN | disclosed |
| WO-2021116528-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | ABACUS DIAGNOSTICA OY (FI) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021116528-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | ABACUS DIAGNOSTICA OY (FI) | 2021-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435365-B2 | Luminescent lanthanide(III) chelates | LAGE3, LAP3, RPL3 | GRM5 2648/4885HAO1 4462/4885HDAC8 2734/4885 |
| US-20230025102-A1 | LUMINESCENT LANTHANIDE(III) CHELATES | LAGE3, LAP3, RPL3 | GRM5 2648/4885HAO1 4462/4885HDAC8 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.